Immunovant Inc. Common Stock vs Ondas Inc. Common Stock — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Ondas Inc. Common Stock trades at $6.96 (market cap $4.19B). The key difference: Immunovant Inc. Common Stock is the larger of the two by market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, Ondas Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Ondas Inc. Common Stock for 0 Days on average.
| IMVT | ONDS | |
|---|---|---|
Market Cap | $6.62B | $4.19B |
Volume | 1,131,364 | 61,559,166 |
Sector | Health | Technology |
52-Week High | $44.96 | $14.01 |
52-Week Low | $17.03 | $5.25 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.72B | $2.82B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →Ondas provides autonomous systems and private wireless solutions through its Ondas Autonomous Systems, Ondas Capital, and Ondas Networks business units. Its technologies combine aerial intelligence and next-generation connectivity for essential industries.
Read more on ONDS →